StemCell Institute
TSE:7096
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| JP |
|
StemCell Institute
TSE:7096
|
8.5B JPY |
Loading...
|
|
| US |
|
CVS Health Corp
NYSE:CVS
|
99.7B USD |
Loading...
|
|
| US |
|
Cigna Corp
NYSE:CI
|
78.2B USD |
Loading...
|
|
| US |
C
|
Cigna Group
XMUN:CGN
|
63.5B EUR |
Loading...
|
|
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
27.9B EUR |
Loading...
|
|
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23.9B EUR |
Loading...
|
|
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
23B USD |
Loading...
|
|
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.3B USD |
Loading...
|
|
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.8B EUR |
Loading...
|
|
| US |
|
Guardant Health Inc
NASDAQ:GH
|
12.6B USD |
Loading...
|
|
| US |
|
DaVita Inc
NYSE:DVA
|
10B USD |
Loading...
|
Market Distribution
| Min | -122 700% |
| 30th Percentile | 2.9% |
| Median | 5.4% |
| 70th Percentile | 8.5% |
| Max | 63 031.4% |
Other Profitability Ratios
StemCell Institute
Glance View
StemCell Institute KK engages in stem cell banking business. The company is headquartered in Minato-Ku, Tokyo-To and currently employs 82 full-time employees. The company went IPO on 2021-06-25. The firm operates Cell Bank business segment. After signing the contract for the separation and storage of umbilical cord blood with customers (pregnant women), the umbilical cord blood collected at domestic umbilical cord blood collection cooperative hospitals (university hospitals, obstetric clinics and others) is collected, and carried into its cell processing center in Minato-ku, Tokyo. The company will be stored at its own cell storage center (Midori-ku, Yokohama, Kanagawa) for a long time at ultra-low temperature after stem cells contained in cord blood being separated, extracted and prepared.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for StemCell Institute is 7.1%, which is below its 3-year median of 12.1%.
Over the last 3 years, StemCell Institute’s Net Margin has decreased from 9.4% to 7.1%. During this period, it reached a low of 7.1% on Sep 30, 2025 and a high of 16% on Sep 30, 2024.
